Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cayston (Aztreonam Lysine) in Participants With Bronchiectasis
NCT03696290Phase 4Terminated
- Sponsor
- University of Dundee
- Start
- Oct 2019
- Primary completion
- Nov 2024
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of aztreonam in bronchiectasis (4 arms), sponsored by University of Dundee. Primary endpoint: Number of adverse events, serious adverse events and trial treatment withdrawals at 12 months. Started Oct 2019; status: terminated.
02
Drugs
aztreonam
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on NCT03696290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03696290.